DNA Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Memedmemed.comin𝕏May 2026 · $14M
MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers.
AI & Machine LearningHealthtechMedical Devices
Co-investorsQualcomm VenturesBridge OneDGF
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.